1. Neuropsychiatric Events in Systemic Lupus Erythematosus
- Author
-
S. Sam Lim, Michelle Petri, Søren Jacobsen, Diane L. Kamen, Juanita Romero-Diaz, Ronald F van Vollenhoven, Daniel J. Wallace, Ann E. Clarke, Caroline Gordon, Rosalind Ramsey-Goldman, Anca Askanase, Paul R. Fortin, Sang Cheol Bae, Cynthia Aranow, Mary Anne Dooley, John G. Hanly, Graciela S. Alarcón, David A. Isenberg, Meggan Mackay, Joan T. Merrill, Murray B. Urowitz, Kenneth C. Kalunian, Jorge Sánchez-Guerrero, Ian N. Bruce, Guillermo Ruiz-Irastorza, Murat Inanc, Dafna D. Gladman, Anisur Rahman, Sasha Bernatsky, Vernon T. Farewell, Christine A. Peschken, Andreas Jönsen, Ellen M. Ginzler, Susan Manzi, Clinical Immunology and Rheumatology, AII - Inflammatory diseases, and AMS - Musculoskeletal Health
- Subjects
Adult ,Male ,medicine.medical_specialty ,Multivariate analysis ,Clinical Sciences ,Immunology ,Lupus ,Negative association ,Autoimmune Disease ,Article ,Young Adult ,Sex Factors ,Theoretical ,Rheumatology ,Models ,Clinical Research ,Postsecondary education ,immune system diseases ,Internal medicine ,Humans ,Lupus Erythematosus, Systemic ,Immunology and Allergy ,Medicine ,In patient ,Longitudinal Studies ,Prospective Studies ,skin and connective tissue diseases ,Lupus Erythematosus ,business.industry ,Inflammatory and immune system ,Systemic ,Headache ,Evaluation of treatments and therapeutic interventions ,Middle Aged ,Models, Theoretical ,INCEPTION COHORT ,Resolution rate ,Arthritis & Rheumatology ,3. Good health ,African race ,6.1 Pharmaceuticals ,Public Health and Health Services ,Quality of Life ,Female ,Asian race ,business - Abstract
ObjectiveTo determine predictors of change in neuropsychiatric (NP) event status in a large, prospective, international inception cohort of patients with systemic lupus erythematosus (SLE).MethodsUpon enrollment and annually thereafter, NP events attributed to SLE and non-SLE causes and physician-determined resolution were documented. Factors potentially associated with the onset and resolution of NP events were determined by time-to-event analysis using a multistate modeling structure.ResultsNP events occurred in 955 (52.3%) of 1,827 patients, and 593 (31.0%) of 1,910 unique events were attributed to SLE. For SLE-associated NP (SLE NP) events, multivariate analysis revealed a positive association with male sex (P=0.028), concurrent non-SLE NP events excluding headache (P < 0.001), active SLE (P = 0.012), and glucocorticoid use (P = 0.008). There was a negative association with Asian race (P = 0.002), postsecondary education (P = 0.001), and treatment with immunosuppressive drugs (P = 0.019) or antimalarial drugs (P = 0.056). For non-SLE NP events excluding headache, there was a positive association with concurrent SLE NP events (P < 0.001) and a negative association with African race (P = 0.012) and Asian race (P < 0.001). NP events attributed to SLE had a higher resolution rate than non-SLE NP events, with the exception of headache, which had comparable resolution rates. For SLE NP events, multivariate analysis revealed that resolution was more common in patients of Asian race (P = 0.006) and for central/focal NP events (P < 0.001). For non-SLE NP events, resolution was more common in patients of African race (P = 0.017) and less common in patients who were older at SLE diagnosis (P < 0.001).ConclusionIn a large and long-term study of the occurrence and resolution of NP events in SLE, we identified subgroups with better and worse prognosis. The course of NP events differs greatly depending on their nature and attribution.
- Published
- 2021